Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Allergy Thera. (AGY) Share News

Allergy Therapeutics Vaccine Helps Dust Mite Allergy Symptoms In Study

20th May 2019 13:42

LONDON (Alliance News) - Allergy Therapeutics PLC on Monday said its Acarovac MPL vaccine improved dust mite allergy symptoms during a phase one study.The AM101 study, which was open-label Read More

WINNERS & LOSERS SUMMARY: Footasylum Rises On "Generous" JD Offer

18th Mar 2019 10:44

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - Tinto, up 2.3%, Group, up in Read More

Allergy Therapeutics Surprised As Vaccine Trial Fails Primary Endpoint

18th Mar 2019 10:06

LONDON (Alliance News) - Allergy Therapeutics PLC on Monday said a phase three trial of its birch pollen allergy vaccine did not meet its primary endpoint.Shares in Allergy Therapeutics 43% Read More

Allergy Therapeutics Interim Profit Rises 67% On Higher Revenue

6th Mar 2019 11:13

LONDON (Alliance News) - Allergy Therapeutics PLC on Wednesday reported significantly higher profit for the first six months of its financial year as revenue rose and research costs were the to of Read More

Allergy Therapeutics First Half Meets Forecasts On European Growth

16th Jan 2019 12:26

LONDON (Alliance News) - Allergy immunology vaccines developer Allergy Therapeutics PLC said Wednesday trading in the first half was in line with expectations.Allergy Therapeutics expects - Read More

Allergy Therapeutics Continues To Perform Well, Revenue Up "Strongly"

27th Nov 2018 13:12

LONDON (Alliance News) - Allergy Therapeutics PLC said Tuesday it has continued to perform well, with revenue up "strongly" from the prior year and sales in line with market financial to Read More

BlackRock Lowers Allergy Therapeutics Stake Below Threshold (ALLISS)

23rd Oct 2018 16:11

LONDON (Alliance News) - Allergy Therapeutics PLC said Tuesday that BlackRock Inc lowered its stake in the company to below the 5% threshold.Prior to the deal, BlackRock held a 5.1% in the Read More

Allergy Therapeutics Interim Loss Widens But Germany Pushes Revenue Up

26th Sep 2018 12:42

LONDON (Alliance News) - Allergy Therapeutics PLC on Wednesday said its loss widened in the first half of 2018, but revenue rose on strong performance in Germany and a strengthening of the company Read More

Allergy Therapeutics To Raise GBP11 Million Via Share Issue (ALLISS)

19th Jul 2018 11:08

LONDON (Alliance News) - Allergy Therapeutics PLC said Thursday that it will raise up to GBP10.6 million via placing and subscription.The pharmaceutical company focused on allergy vaccines Read More

Allergy Therapeutics Reveals Good Results From Dust Mite Allergy Tests

29th May 2018 11:19

LONDON (Alliance News) - Biotechnology firm Allergy Therapeutics PLC said it will present positive new data on its dust mite allergy treatment at a congress in Germany on Tuesday.Allergy is Read More

Allergy Therapeutics Reports Positive Results From Grass Pollen Study

21st May 2018 11:49

LONDON (Alliance News) - Allergy Therapeutics PLC said Monday it saw positive results from its grass pollen allergy treatment phase II dose ranging study as it prepares to commence in phase III it Read More

Allergy Therapeutics Gets Positive Indications In Latest MCT Study

14th May 2018 12:24

LONDON (Alliance News) - Biotechnology firm Allergy Therapeutics PLC on Monday said it has received positive new data in a study investigating its microcrystalline tyrosine-based results, it said, Read More

DIRECTOR DEALINGS: Allergy Therapeutics Non-Executive Lifts Stake

16th Mar 2018 17:30

LONDON (Alliance News) - Pharmaceutical company Allergy Therapeutics PLC said Friday Non-Executive Director Tunde Otulana acquired shares on Thursday.Otulana acquired a Read More

Allergy Therapeutics Profit Falls On Costs As Pivotal Year Looms

7th Mar 2018 13:42

LONDON (Alliance News) - Allergy Therapeutics PLC said Wednesday half year profit fell due to higher research and development costs, as the company prepares for 2018 clinical Read More

Allergy Therapeutics' House-Dust Mite Allergy Vaccine Trial Approved

14th Feb 2017 08:49

Allergy Therapeutics Granted EU Patent For Microcrystalline Tyrosine

2nd Nov 2016 09:29

DIRECTOR DEALINGS: Allergy Therapeutics Chairman Lifts Stake

29th Sep 2016 11:55

DIRECTOR DEALINGS: Allergy Therapeutics Finance Boss Buys First Shares

28th Sep 2016 10:41

Allergy Therapeutics Expects Revenue Rise Despite Euro Weakening

13th Jul 2016 08:43

Allergy Therapeutics Welcomes Positive Follow-Up Results For Acarovac

8th Jul 2016 07:26

FTSE 100 Latest

Value10,223.54

Change51.78